The global Empty Intravenous (IV) Bags Market size was USD 1.37 billion in 2022 and is expected to grow to USD 2.69 billion in 2032, with a rapid revenue CAGR of 7.8% during the forecast period. The market is being driven by the increasing prevalence of chronic diseases, including cancer, diabetes, and kidney failure, which require constant IV drug administration.

Additionally, the adoption of parenteral nutrition and intravenous medication in homecare settings is increasing the use of empty IV bags. Technological advancements, such as multi-chamber bags and eco-friendly materials, are also expected to drive revenue growth of the market.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/6358

Multi-chamber bags reduce the risk of medication errors and infection by allowing the administration of multiple drugs or solutions through a single IV line. Eco-friendly materials are safer for patients and the environment.

Key players in the Empty Intravenous (IV) Bags Market –

• Baxter International Inc.
• B. Braun Melsungen AG
• Hospira Inc.
• West Pharmaceutical Services Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Renolit SE
• Kraton Corporation
• Polycine GmbH
• PolyCine Asia Pacific Sdn Bhd

The demand for sterile and single-use empty IV bags is increasing due to the rising focus on reducing Healthcare-Associated Infections (HAIs). Customized empty IV bags that are tailored according to the specific needs of patients are also expected to drive revenue growth.

The market's growth is being further fueled by the increasing number of surgical procedures and hospital admissions, the rising geriatric population, and the increasing prevalence of chronic diseases. Furthermore, governments and private organizations are investing more in the healthcare industry, such as the Indian government's announcement of a USD 1.5 billion package for boosting the healthcare sector in 2020.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/6358

However, the market's revenue growth could be restrained by alternative drug delivery methods such as oral medications and inhalers and a strict regulatory framework governing the manufacturing and use of IV bags. Additionally, high production costs and concerns regarding the disposal of empty IV bags could also restrain market revenue growth.

The global empty IV bags market is segmented into PVC and non-PVC based on material type. The PVC segment accounted for the largest revenue share in the market due to its cost-effectiveness and high availability. The non-PVC segment is expected to register the fastest revenue growth rate during the forecast period due to concerns regarding the toxicity of PVC materials and their impact on the environment.

Based on end-use, the market is segmented into hospitals, clinics, and Ambulatory Surgical Centers (ASCs). Hospitals accounted for a significantly large revenue share due to high patient volumes and the need for a wide range of medical services. Clinics are expected to register steady fast revenue growth due to the rising demand for outpatient services and development of advanced medical technologies. ASCs are expected to account for a considerably large revenue share due to the increasing number of ASCs and rising demand for outpatient surgical procedures.

North America accounted for the largest revenue share in the global empty IV bags market in 2022 due to the increasing number of patients requiring IV therapy, adoption of parenteral nutrition therapy, and prevalence of chronic diseases such as cancer and diabetes. Europe and the Asia Pacific are expected to follow North America in terms of market revenue growth during the forecast period.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/6358

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Browse for more reports: